FDA Orders New Eye-Risk Warning Labels for Ozempic, Wegovy
Listen to the story
The US FDA (Food and Drug Administration) has ordered new warning labels for several popular weight-loss and diabetes drugs.
The drugs affected include Ozempic, Wegovy, and Zepbound. They belong to a group of medicines called GLP-1 drugs.
GLP-1 drugs have become very popular in recent years because they help people lose weight and manage blood sugar levels.
The FDA says these drugs carry a rare risk of vision loss. In some cases, this vision loss may be permanent, meaning it does not improve over time.
Because of this risk, the FDA has ordered drug makers to add new warning labels to the medicines' packaging.
This step is meant to make sure patients and doctors understand the possible side effect before starting treatment.
The FDA did not say that the drugs are unsafe for most people. Instead, it wants the risk to be clearly listed so people can make informed choices.
GLP-1 drugs work by copying a natural hormone in the body that controls appetite and blood sugar.
Millions of people currently use these drugs, mainly for weight loss or to treat type 2 diabetes.
The new warning will likely appear on updated prescribing information given to doctors and pharmacists.
Health officials continue to study the drugs to better understand how common this rare eye risk actually is.
Vocabulary9 words
- FDA
- the US government agency that checks medicine safety
- GLP-1
- a group of drugs used for weight loss and diabetes
- blood sugar
- the amount of sugar in a person's blood
- vision loss
- losing the ability to see clearly
- permanent
- lasting forever; cannot be changed back
- warning label
- text on a product that explains a danger
- side effect
- an unwanted result caused by a medicine
- hormone
- a natural chemical that controls body functions
- prescribing information
- official details doctors read about a medicine
📚 Ready to use these words in a real conversation?
Practice live with a real tutor on Preply.
Quiz
Answer key
1. It ordered new warning labels about vision loss 2. Ozempic, Wegovy, and Zepbound 3. Rare
✅ Nice work on the quiz!
Keep the momentum going — book a live English lesson with a Preply tutor.
Fill-in-the-blank listening
Play the audio again and fill in the missing words as you listen.
The US FDA has ordered new _____ for several popular weight-loss and diabetes drugs.
The drugs affected include Ozempic, Wegovy, and Zepbound, part of a group called _____ drugs.
These drugs have become popular because they help manage _____ levels and support weight loss.
The FDA says the drugs carry a rare risk of _____, which may be _____ in some cases.
Drug makers must now add new warning labels to explain this _____.
The FDA wants patients and doctors to understand the risk before starting _____.
GLP-1 drugs work by copying a natural _____ that controls appetite and blood sugar.
The new warning will appear in updated _____ given to doctors and pharmacists.
🎓 Enjoyed this story?
Turn today's reading into real speaking practice with a live Preply tutor.
More Health stories
Next story · Medium
Tech Billionaire Jensen Huang Caught in Spy Scandal